Dow Up0.51% Nasdaq Up0.24%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.70 Up 0.17(1.09%) 4:00PM EST
|After Hours : 15.72 Up 0.02 (0.13%) 6:15PM EST - Nasdaq Real Time Price
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents55,696  14,677  35,252  
Short Term Investments -   -  4,211  
Net Receivables -   -  7  
Inventory -   -   -  
Other Current Assets1,232  430  534  
Total Current Assets 56,928   15,107   40,004  
Long Term Investments -   -   -  
Property Plant and Equipment349  56  67  
Goodwill3,208  3,208  3,208  
Intangible Assets -   -   -  
Accumulated Amortization -   -   -  
Other Assets281  198  209  
Deferred Long Term Asset Charges -   -   -  
Total Assets 60,766   18,569   43,488  
Liabilities
Current Liabilities
Accounts Payable15,328  8,039  9,767  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities -   -   -  
Total Current Liabilities 15,328   8,039   9,767  
Long Term Debt -   -   -  
Other Liabilities38  36  2,674  
Deferred Long Term Liability Charges -   -   -  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 15,366   8,075   12,441  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock83  72  71  
Retained Earnings(439,340)(392,608)(369,887)
Treasury Stock(357)(357)(357)
Capital Surplus485,014  403,387  401,220  
Other Stockholder Equity -   -   -  
Total Stockholder Equity 45,400   10,494   31,047  
Net Tangible Assets 42,192   7,286   27,839  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.